US Stock MarketDetailed Quotes

BEAM Beam Therapeutics

Watchlist
  • 27.070
  • +1.130+4.36%
Trading Jul 22 15:22 ET
2.23BMarket Cap-16918P/E (TTM)

Beam Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Beam Therapeutics Earnings Date

Currency: USD

Period

Q1 FY2024 Earnings

--

Revenue(YoY)

7.41M

-69.39%
EPS(YoY)

-1.21

+9.02%
Analyst Rating

Buy

Jul 22, 2024

Beam Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 11 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 12.869M--
--2024/Q2-- / 12.414M--
--2024/Q17.410M / 14.664M--
--2023/Q4316.192M / 33.673M--
--2023/Q317.193M / 23.893M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 12.869M--
--2024/Q2-- / 12.414M--
--2024/Q17.410M / 14.664M--
--2023/Q4316.192M / 33.673M--
--2023/Q317.193M / 23.893M--

Unlock Free Earnings Estimates

Beam Therapeutics Earnings Reports

  • Beam Therapeutics | 10-Q: Quarterly report

    May 7 07:24 ET

  • Beam Therapeutics | 10-K: Annual report

    Feb 27 07:25 ET

  • Beam Therapeutics: Q3 2023 Earnings Report

    Nov 8, 2023 07:30 ET

  • Beam Therapeutics | 10-Q: Q2 2023 Earnings Report

    Aug 8, 2023 07:30 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Jul 22, 2024

    Buy

    • Buy

      55.56%

    • Hold

      44.44%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    %Chg
    Concept ARK Holdings
    ARK Holdings
    Intraday+3.60%
    Gene Editing
    Gene Editing
    Intraday+0.66%